Suchergebnisse - "Menzies-Gow, Andrew"

PubPharm (15)

1

Effect of Tezepelumab on Lung Function in Patients With Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study

enthalten in: Advances in therapy | 2023

von Menzies-Gow, A. | Ambrose, C. | Colice, G. | +5

2

Tezepelumab for the treatment of severe asthma : a plain language summary of the PATHWAY and NAVIGATOR studies

enthalten in: Immunotherapy | 2023

von Corren, J. | Menzies-Gow, A. | Bimmel, J. | +11

3

Effect of tezepelumab on healthcare utilization in patients with severe, uncontrolled asthma : The NAVIGATOR study

enthalten in: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology | 2023

von Menzies-Gow, A. | Bourdin, A. | Chupp, G. | +9

4

Efficacy of Tezepelumab in Severe, Uncontrolled Asthma : Pooled Analysis of the PATHWAY and NAVIGATOR Clinical Trials

enthalten in: American journal of respiratory and critical care medicine | 2023

von Corren, J. | Menzies-Gow, A. | Chupp, G. | +13

CommentIn: Ann Intern Med. 2023 Nov;176(11):JC128. - PMID 37931261

5

Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION) : a randomised, placebo-controlled extension study

enthalten in: The Lancet. Respiratory medicine | 2023

von Menzies-Gow, A. | Wechsler, M. | Brightling, C. | +114

CommentIn: Lancet Respir Med. 2023 Jan 23;:. - PMID 36702145

6

Efficacy of tezepelumab in patients with evidence of severe allergic asthma : Results from the phase 3 NAVIGATOR study

enthalten in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology | 2023

von Corren, J. | Ambrose, C. | Griffiths, J. | +5

7

Not just an anti-eosinophil drug : tezepelumab treatment for type 2 asthma and beyond

enthalten in: The European respiratory journal | 2023

von Corren, J. | Brightling, C. | Boulet, L. | +8

8

Efficacy and safety of tezepelumab in patients recruited in Japan who participated in the phase 3 NAVIGATOR study

enthalten in: Allergology international : official journal of the Japanese Society of Allergology | 2023

von Ishizuka, T. | Menzies-Gow, A. | Okada, H. | +7

9

Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE) : a randomised, placebo-controlled, phase 3 study

enthalten in: The Lancet. Respiratory medicine | 2022

von Wechsler, M. | Menzies-Gow, A. | Brightling, C. | +72

ErratumIn: Lancet Respir Med. 2022 Apr 5;:. - PMID 35395206

10

Tezepelumab compared with other biologics for the treatment of severe asthma : a systematic review and indirect treatment comparison

enthalten in: Journal of medical economics | 2022

von Menzies-Gow, A. | Steenkamp, J. | Singh, S. | +6